Eton Pharmaceuticals, Inc. ETON Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Eton Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →
Ask your AI about Eton Pharmaceuticals, Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eton Pharmaceuticals, Inc.'s return on equity?
- Eton Pharmaceuticals, Inc. (ETON) reported return on equity of -34.2% in Q3 2025.
- How has Eton Pharmaceuticals, Inc.'s return on equity changed year-over-year?
- Eton Pharmaceuticals, Inc.'s return on equity decreased by 2.5% year-over-year, from -33.3% to -34.2%.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s return on equity?
- Over 2 years (2020 to 2024), Eton Pharmaceuticals, Inc.'s return on equity has grown at a -68.9% compound annual growth rate (CAGR), from -198.5% to -19.2%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.